NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Substantial 15-year survival gains from standard treatments



June 2nd, 2005

The types of chemotherapy and hormonal therapy that have long been used to help prevent breast cancer recurrence have much greater effects on 15-year than on 5-year survival, data analysis shows.

This extra effect is one of the main reasons why breast cancer death rates have been falling rapidly ever since the early 1990s in the U.K., the U.S., and some other countries, stated the authors in the May 12, 2005, issue of The Lancet.

In early breast cancer, surgery (or surgery and radiotherapy) can appear to remove all traces of the disease, but undetected deposits of cancer cells may remain that could, over the next 5, 10, or 15 years, develop...


Source: Women's Health Weekly (2005-06-02)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login